Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Trump's touting of an unproven autism drug surprised many, including the doctor who proposed it

A Trump administration decision to repurpose an old chemotherapy drug for autism has surprised many experts — including the physician who recently proposed the idea

The Independent UK

Tylenol maker prepares for glut of lawsuits after Trump’s baseless warnings

‘Don’t take Tylenol,’ President Donald Trump repeatedly warned on Monday

The Independent UK

Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients

Atai Life Sciences (NASDAQ:ATAI) and Beckley Psytech Limited, a private clinical-stage biopharmaceutical company, released data from a proof-of-concept study investigating a two-dose induction regimen of BPL-003 (intranasal mebufotenin benzoate) in patients with treatment-resistant depression (TRD).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

HIMS Stock Just Got Rocked (Again) By the FDA. This Analyst Still Thinks Hims & Hers Can Surge 50%.

Despite a sharp selloff after the latest FDA warning, Hims & Hers continues to post triple-digit annual gains and strong revenue growth, with at least one analyst projecting a 50% upside.

Barchart

Is Tylenol the same as paracetamol, and should you take it in pregnancy? Here’s why experts say Trump should be ignored

The US president claims the painkiller also known as acetaminophen is linked to autism. Here’s what the science says

The Guardian - UK

ARS Pharma Urges FDA To Delay Approval Of Aquestive's Allergic Reaction Treatment

ARS Pharmaceuticals Inc. (NASDAQ:SPRY) filed a petition Monday urging the FDA to delay approval of Aquestive Therapeutics Inc.'s (NASDAQ:AQST) experimental epinephrine treatment, citing safety, dosing, and real-world use concerns.

Benzinga

Fact-checking Trump's paracetamol and autism announcement

President Donald Trump made several claims during his conference to announce a ‘link’ between Tylenol and autism - but how much is true?

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

What's Going On With Kenvue Stock Tuesday?

Kenvue Inc. (NYSE:KVUE) shares are trading higher Tuesday despite President Donald Trump saying the Food and Drug Administration will notify physicians that use of acetaminophen or Tylenol during pregnancy could be associated with increase risk of autism.

Benzinga

Scholar Rock's Spinal Muscular Atrophy Drug Faces FDA Delay Over Catalent Indiana Inspection

The U.S. Food and Drug Administration (FDA) on Tuesday issued a Complete Response Letter (CRL) for Scholar Rock’s (NASDAQ:SRRK) apitegromab Biologics License Application (BLA) for spinal muscular atrophy (SMA).

Benzinga

The 7 Dirtiest Secrets of the Food Industry

The modern food industry is a miracle of science and logistics. It is also an industry that is filled with several shocking and often unappetizing secrets. To produce the huge amount of cheap and consistent food that we demand, the industry relies on a variety of controversial practices and ingredients.…

Grocery Coupon Guide

Trump’s inability to pronounce acetaminophen draws laughter from across the internet

‘If you can’t pronounce acetaminophen, you probably shouldn’t be giving out medical advice related to acetaminophen,’ one X user suggested

The Independent UK

2 ‘Strong Buy’ Stocks That Wall Street Believes Can Soar 360% to 780%

These two growth stocks are attractive for investors seeking big upside in exchange for higher risk.

Barchart

Donald Trump claims of paracetamol link to autism should be ignored, Wes Streeting says

Health Secretary says expectant mothers should listen to doctors over US president on medical matters

Evening Standard

Trump Administration Backs Leucovorin for Autism — How It Works, the Science Behind It and Its Effectiveness

The Trump administration has backed the use of leucovorin, a folate-based drug, for autism treatment. Here's what the science says, how it works, and why experts are divided on its effectiveness.

International Business Times UK

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times UK

Paracetamol, Autism and Panic: How to Read the Science Before You Change Your Pregnancy Plan

UK health bodies reaffirm paracetamol is safe in pregnancy after Trump autism claims. Experts warn misinformation could deter vital treatment.

International Business Times UK

White House Slammed for Tylenol-Autism Claim as Experts Insist 'It's the Vaccines' Driving Autism Fears

Experts blast Trump's Tylenol-autism claims, stressing vaccines are safe and misinformation, not paracetamol, drives autism anxiety.

Latin Times

Trump's Cuba, Tylenol and Autism Theory Collides with Reality: What Experts in Havana Say

President Donald Trump caused a stir when he connected autism, acetaminophen (commonly known by the brand name Tylenol in the U.S.), and the island of Cuba during a White House announcement.

Roll Call

Trump, officials link Tylenol to autism as medical community balks - Roll Call

President Trump and his health team advise against taking Tylenol during pregnancy, rebuking long-standing public health guidance.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

More shrimp sold at Kroger stores recalled for possible radioactive contamination

A Seattle seafood distributor has recalled more cooked and frozen shrimp sold at Kroger grocery stores across the U.S. because of ongoing concerns about potential radioactive contamination

Benzinga

FDA Clears Merck's One-Minute Cancer Shot

The U.S. Food and Drug Administration (FDA) on Friday approved Merck Co. Inc.’s (NYSE:MRK) Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) injection for subcutaneous administration in adults across most solid tumor indications for Keytruda.

Benzinga

FDA Delays Key Sanofi Multiple Sclerosis Drug Decision

On Monday, the U.S. Food and Drug Administration (FDA) extended the review date for Sanofi SA’s (NASDAQ:SNY) new drug application (NDA) of tolebrutinib for non-relapsing, secondary progressive multiple sclerosis (nrSPMS) and to slow disability accumulation independent of relapse activity in adult patients.

Marie Claire

Could This Be the Cure?

For decades, a New York writer struggled to understand why she felt so stuck. It wasn't until she tried MDMA —and finally processed a dark episode from her past—that she got her answer.

Medical Daily

Trump to Discuss New Autism Findings After Hinting At Major Discovery During Kirk Memorial

US President Trump may address autism findings, Tylenol risks during pregnancy, and potential treatments including leucovorin in a new briefing.

Benzinga

Trump Administration To Unveil Tylenol-Autism Review, Tout This Drug As Potential Treatment: Report

The Trump administration is expected to unveil new efforts on Monday examining whether one widely used drug may be linked to autism and whether another could help treat it, according to people familiar with the plans who spoke to The Washington Post on condition of anonymity because the announcement was…

International Business Times UK

Trump Autism Update: US President Set to Discuss Autism Findings, Potential Tylenol Connection and Cure Options

US President Trump may address autism findings, Tylenol risks during pregnancy, and potential treatments including leucovorin in a new briefing.

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.